Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Trading Statement

12 Jul 2007 07:00

Cello Group plc12 July 2007 12 July 2007 Cello Group plc Pre Close Trading Statement - six months to 30 June 2007 Cello Group plc ("Cello" AIM: CLL), the research and consulting group, todayprovides the following pre-close trading update for the six months to 30 June2007. Cello has continued to make good progress and the Board is confident about theGroup's outcome for the full year. The research and consulting business continues to perform well and on a fullyear basis is expected to deliver healthy growth. Our response business will bemore heavily second half weighted than in the past, but given good revenuevisibility which has strengthened since the AGM statement on 22 May, we areconfident about the full year outcome for this business. Our research and consulting business which now accounts for around 75% of theGroup on an operating profit basis has benefited from the investments made innew staff and product offering during the course of 2006 and the first half of2007. We have seen significant revenue growth from existing clients as well as anumber of large new client wins, particularly internationally. Internationalwork now accounts for 45% of the revenues of this division. The size ofcontracts we are pitching for and also winning has increased markedly, helpingdrive good like for like revenue growth. During the first six months of 2007, we further strengthened our healthcareresearch and consulting capability with the acquisition of The MSI Consultancyin March. In June, mruk research also joined the Group, strengthening ourresearch offer to the public sector. We have also made significant strides in building our online research business.In February we acquired a controlling interest in Digital People and Rosenblatt,and more recently we purchased a significant minority share in nqual, a dynamiconline qualitative research company. Our response business which comprises 25% of the Group continues to build astrong position in the sector, with healthy like for like revenue growth basedon good levels of revenue visibility. The seasonal split between the first andsecond half has continued to widen as the growth of the business has seen aparticular focus on clients with a seasonal spending pattern in both charitiesand financial services. This seasonality will affect like for like growth at aprofit level for the six months to 30 June but not on a full year basis where weare confident of good profit growth. We continue to increase the online component of our response offering, boththrough our separate branded offerings, Blonde and Oomph, as well as theincreasing component of our core offer that is now digital. On 6 July we announced the acquisition of cchm:ping, a specialist financialservices marketing agency and the establishment of a consulting offer in thissector vertical. In line with our prudent financing policy, Cello has maintained a strong balancesheet with low gearing. Cello expects to announce its interim results for the six months to 30 June 2007on Tuesday 11 September 2007. These results will be prepared under IFRS, and atransition statement will be issued prior to that date. Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Ben Way 020 7457 2020 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of ÂŁ100million, gross profits of overÂŁ50 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.